A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice

International Journal of Pharmacy Practice

Volumn 15, Issue 1, 2007, Pages 39-46

  Bond, Christine M ^a,b   Fish, Alison ^a   Porteous, Terry H ^a,d   Reid, John P ^a   Scott, Anthony ^c   Antonazzo, Emanuela ^b  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PHARMACEUTICAL CARE; PHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRAINING; UNITED KINGDOM;

EID: 33847696979     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.15.1.0007     Document Type: Article

References (28)

1. Zermansky AG. Who controls repeats? Br J Gen Pract 1996;46:643-7.
2. Burtonwood AM, Hinchcliffe AL, Tinkler GG. A prescription for quality: a role for the clinical pharmacist in general practice. Pharm J 1998;261:678-80.
3. Primary care: agenda for action: February 1997. Edinburgh: The Scottish Office, Department of Health; 1996. pp. 126-7.
4. The Scottish Health Service: ready for the future. Edinburgh: The Scottish Office, Department of Health; 1997.
5. Department of Health. Implementing the new community pharmacy contractual framework. London: Department of Health; 2005.
6. Modernising NHS community pharmacy in Scotland, introduction of new community pharmacy contract. Edinburgh: Scottish Executive; 2005.
7. Supplementary prescribing. London: Department of Health; 2003.
8. Improving patients' access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England. London: Department of Health; 2006.
9. Webb RJ, Barton SB. Enabling community pharmacists to advise prescribers. Pharm J 1996;257:126-7.
10. Bond CM, Sinclair HK, Taylor RJ et al. Pharmacists: a resource for general practice. Int J Pharm Pract 1995;3:85-90.
11. Sykes D, Westwood P. Training community pharmacists to advise GPs on prescribing. Pharm J 1997;258:417-19.
12. Beney J, Bero LA, Bond CM. Expanding pharmacists' roles and health services utilisation, costs and patient outcomes (Cochrane Review). The Cochrane Library. Oxford: Update Software; 2001.
13. Fish A, Watson MC, Bond CM. Practice based pharmaceutical services: a systematic review. Int J Pharm Pract 2002;10:225-33.
14. Zermansky AG, Petty DR, Raynor DK et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323:1340-3.
15. Mackie CA, Lawson DH, Campbell A, Maclaren AG, Waigh R. A randomised controlled trial of medication review in patients receiving polypharmacy in general practice. Pharm J 1999;263:R7.
16. Jarman B. Underprivileged areas: validation and distribution of scores. BMJ 1984;298:1587-92.
17. Medication review. Edinburgh: Scottish Centre for Post-qualification Pharmaceutical Education; 1997.
18. Kind P. The EuroQol Instrument: an index of health related quality of life. In: Spiker B, editor. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia: Lippincott-Raven; 1996. pp 191-200.
19. Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ 1986;56:1-188.
20. Dupuy HJ. (1984), The Psychological General Well-Being Index. In Wenger N, Mattson M, Furberg C, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq. pp 170-83.
21. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001;323:142-6.
22. Chemist and druggist price list. London: CMP Information Ltd; 1999.
23. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves BMJ 1990;300:981-3.
24. Cochrane Collaboration on Effective Professional Practice. The Cochrane Collaboration on Effective Professional Practice data collection checklist. York: Department of Health Sciences and Clinical Evaluation, University of York; 1996.
25. Data Protection Act. London: Department for Constitutional Affairs UK; 1998
26. Caldicott report. London: Health Protection Agency; 1997.
27. Krska J, Cromarty J, Arris F, Jamieson D, Hansford D. Providing pharmaceutical care using a systematic approach. Pharm J 2000;265:656-9.
28. van Mil WF, TrompTFJ. Pharmaceutical care in the Netherlands. History, definition and projects. J Pharm World Sci 1996;18:237-40.